ABOUT US
Jazz Pharmaceuticals plc is a specialty biopharmaceutical company dedicated to helping patients with unmet medical needs. We identify, develop and commercialize innovative products in focused therapeutic areas, with a strong commercial focus and expertise in narcolepsy, severe chronic pain, psychiatry and women’s health.
Our marketed product portfolio includes: XYREM® (sodium oxybate), PRIALT® (ziconotide intrathecal injection), FAZACLO® (clozopine, USP) LD and HD , LUVOX CR® (fluvoxamine maleate), and ELESTRIN® (estradiol gel 0.06%).
The product information on XYREM, PRIALT, FAZACLO LD, FAZACLO HD, LUVOX CR and ELESTRIN is intended only for residents of the United States. For more information, including complete prescribing information and boxed warnings, click on the product names above.
We plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our unique commercial expertise. As we evaluate acquisition and in-licensing opportunities, we work closely with healthcare professionals and patient advocates to identify significant treatment gaps where Jazz Pharmaceuticals’ unique approach to patient care and “high touch” products may be able to bring a new therapeutic option to the market where none existed previously.
CORE VALUES
Our core values define our corporate practices and demonstrate our commitment to improving patients’ lives.
COMMERCIAL CAPABILITIES
We’ve built a “high touch” commercial team with the goal of creating a sophisticated and specialized organization to serve the needs of the patient.